Eva Akurut is a PhD candidate in bioinformatics and data science at Makerere University, supported by the SHE DATA Program under the African Centre of Excellence in Bioinformatics and Data-Intensive Sciences (ACE). Her research focuses on non-small cell lung cancer (NSCLC) at the intersection of computational immuno-oncology, tumor immunology, and vaccine design. During her PhD, Akurut aims to develop a multi-epitope neoantigen-based vaccine for NSCLC that targets T-cell responses. She will do so by integrating whole exome sequencing (WES), RNA-Seq, and circulating tumor DNA (ctDNA) to identify somatic mutations that drive tumor-specific immune responses. A central component of her research is understanding the tumor microenvironment (TME) and T-cell receptor (TCR) antigen interactions, alongside HLA typing that predicts population-relevant epitopes. By understanding which mutations are neoantigens and how T-cell repertoires, HLA diversity, and immune contexture influence neoantigen recognition, she hopes to design a T-cell-centric vaccine capable of inducing durable, efficacious anti-tumor immunity. She has prior experience gained during her work at the Medical Research Council (MRC)/UVRI & LSHTM Uganda Research Unit. While here, she gained hands-on experience in cellular immunology, including T-cell phenotyping, cytokine profiling, and immune activation assays. This experimental background is the anchor of her computational immunology work, allowing the connection of in